Q1 2026 Holdings
Filed 2026-05-13 | 16 holdings | $652.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $258.1M | 2,449,183 | 39.6% |
| Nanobiotix S.A.(NBTX) | SPONSORED ADS | 63009J107 | $173.6M | 5,623,816 | 26.6% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $57.5M | 6,641,064 | 8.8% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $55.8M | 1,784,517 | 8.6% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $38.1M | 4,024,861 | 5.8% |
| Contineum Therapeutics Inc.(CTNM) | CL A | 21217B100 | $25.8M | 1,979,173 | 4.0% |
| Legend Biotech Corporation(LEGN) | SPONSORED ADS | 52490G102 | $14.7M | 814,586 | 2.3% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $9.0M | 748,062 | 1.4% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $9.0M | 357,939 | 1.4% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $4.1M | 3,379,064 | 0.6% |
| Neumora Therapeutics, Inc.(NMRA) | COM | 640979100 | $3.6M | 1,849,445 | 0.6% |
| Rallybio Corporation(RLYB) | COM | 75120L209 | $1.4M | 152,901 | 0.2% |
| Vor Biopharma, Inc.(VOR) | COM NEW | 929033207 | $958.6K | 53,732 | 0.1% |
| Standard BioTools, Inc.(LAB) | COM | 34385P108 | $286.8K | 311,967 | 0.0% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $189.7K | 83,554 | 0.0% |
| Adicet Bio, Inc.(ACET) | COM NEW | 007002207 | $155.1K | 22,779 | 0.0% |